Chronic Kidney Disease Ckd clinical trials

Explore recruiting chronic kidney disease ckd clinical trials.

Recruiting chronic kidney disease ckd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Kidney Disease Ckd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatrics Subjects with Chronic Kidney Disease (CKD)

Lithuania, Hungary, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized clinical study to analyse the effects of dapagliflozin on renal morphology and renal perfusion in patients with impaired renal function one year after kidney transplantation

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Use of tacrolimus and MTOR inhibitors with anticipatory therapy vs. tacrolimus and mycophenolic acid with universal prophylaxis in renal recipients at high risk of post-transplant cytomegalovirus. Phase IV clinical trial (TIMTOR STUDY).

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Beneficial effects of Amiloride on progression of Chronic Kidney Disease: A-CKD

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 3, Single-arm, Open-label, Multidose, Titration, Pharmacokinetic, Pharmacodynamic, and Safety Study of Etelcalcetide in Children and Adolescents ≥ 2 to < 18 Years of age with Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Maintenance Hemodialysis

Czechia, Greece, Germany, Italy, Belgium, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Randomized, Investigator-Blinded, Active-Controlled Study of Efficacy and Safety of Efepoetin Alfa for Treatment of Anemia in Patients with Chronic Kidney Disease on Dialysis

Czechia, Poland, Hungary, Italy, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Kidney Disease Ckd trials by city

Chronic Kidney Disease Ckd in Toronto Chronic Kidney Disease Ckd in Vancouver Chronic Kidney Disease Ckd in Montreal Chronic Kidney Disease Ckd in Calgary Chronic Kidney Disease Ckd in Edmonton Chronic Kidney Disease Ckd in Ottawa Chronic Kidney Disease Ckd in Winnipeg Chronic Kidney Disease Ckd in Quebec City Chronic Kidney Disease Ckd in Hamilton Chronic Kidney Disease Ckd in Kitchener Chronic Kidney Disease Ckd in London Chronic Kidney Disease Ckd in Halifax Chronic Kidney Disease Ckd in New York Chronic Kidney Disease Ckd in Los Angeles Chronic Kidney Disease Ckd in Chicago Chronic Kidney Disease Ckd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease